Duloxetine Capsule, Delayed Release
Product Images NDC 70518-1011

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 70518-1011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Duloxetine 60mg 70518 1011 00

This is a description of a medication called DULoxetine. It is a capsule with a dosage of 60 mg and is usually sold in a quantity of 30. The medication is delayed-release, making it more effective over time, and must be kept out of the reach of children. The medicine was manufactured in India by Ajanta Pharma Ltd and repackaged by RemedyRepack Inc. The package insert should be consulted for directions, and the medication should be stored in a cool, dry place between 15-30°C (59-86°F).*

FDA Label Image

Duloxetine 60mg 70518 1011 01

This is a bottle of 30 delayed-release 60mg Duloxetine capsules, manufactured by Ajanta Pharma Ltd. in India. The package is Rx-only and has an NDC number of 70518-1011-01. The medication should be kept out of the reach of children and stored at 20-25°C (88-77°F), with excursions permitted to 15-30°C (59-86°F). The lot number and expiration date are not specified in the text. The package insert should be consulted for usage instructions. The bottle has been repackaged by RemedyRepack Inc. in Indiana, PA.*

FDA Label Image

Duloxetine 60mg 70518 1011 02

DULoxetine is a delayed-release medication with a strength of 60mg per capsule, available in a quantity of 60 capsules. It is a prescription drug that needs to be used only as directed in the package insert. Keep it out of the reach of children and store it at a temperature between 20-25°C (88-77°F), with excursions allowed at 15-30°C (59-86°F) [See USP]. This drug has been repackaged by RemedyRepack Inc., Indiana, PA 15701, 724.465.8762, and should be used by the expiry date mentioned on the package. The Lot Number is not available. The source NDC is 27241-0099-90.*

FDA Label Image

Duloxetine Fig1

This data represents a chart showing the treatment response for patients with relapse. The treatments examined are Placebo and Duloxetine, and the chart displays the time in days from randomization to relapse. The x-axis ranges from 0 to 250 and the y-axis ranges from 0.4 to 1.0. No further information is available.*

FDA Label Image

Duloxetine Fig10

This is a medication prescription for Duloxetine, which is a drug used to treat depression, anxiety, and pain. The recommended dosage is either 60 milligrams or 120 milligrams per day. The rest of the text appears to be a graph showing the percentage improvement in pain from baseline after taking the medication.*

FDA Label Image

Duloxetine Fig2

This is a graph showing the proportion of patients who experienced a relapse over time after randomization to treatment with either a placebo or duloxetine. The x-axis shows time in days from randomization to relapse, and the y-axis shows the proportion of patients experiencing relapse. The graph suggests that treatment with duloxetine may be more effective in preventing relapse compared to placebo.*

FDA Label Image

Duloxetine Fig3

The text provides a table with the percentage of patients improved in regards to pain after receiving different doses of Duloxetine and a placebo. The doses mentioned include Duloxetine 60 mg BID, Duloxetine 60 mg QD, and Duloxetine 20 mg QD. The table also lists the percentage improvement in pain from baseline. No further information can be inferred from the text.*

FDA Label Image

Duloxetine Fig4

FDA Label Image

Duloxetine Fig5

This appears to be a chart or graph showing the percentage of patients who have improved while taking either duloxetine 60mg twice daily or duloxetine 60mg once daily compared to a placebo. The chart also shows the percent improvement in pain from baseline.*

FDA Label Image

Duloxetine Fig6

FDA Label Image

Duloxetine Fig8

This is a description of a medical treatment that involves taking placebo medication alongside Duloxetine at doses of 60 or 120 mg once daily. There is a table showing a percent improvement in pain from the baseline. Nonetheless, there also appears to be some random and unreadable characters along with a line of text that says "ponoidw) sjualied jo abejusoiad."*

FDA Label Image

Duloxetine Fig9

This appears to be a graph or chart showing the percent improvement in pain from baseline after taking a placebo or a dosage of 60mg of duloxetine daily. The X-axis ranges from 0 to 100 and the Y-axis ranges from 0 to 250. However, it is not clear what the specific study or condition being treated is.*

FDA Label Image

Duloxetine-structure (Duloxetine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.